$0.729
-0.047 (-6.50%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de TELO por análisis de gráficos similares
Alphio's TELO stock price prediction model matches the current Telomir Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.73 (-0.50%). The 1-week path is $0.75 (+3.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Telomir Pharmaceuticals Inc?
Telomir Pharmaceuticals is currently not a strong buy due to its very low RSI of 18.086, indicating it is oversold, and a significant negative trend with a 1-year change of -38.99%. However, the potential upside is notable with an analyst price target of $4, suggesting a potential increase of over 330% from the current price of $0.92. The main risk is the company's ongoing losses, with a last earnings EPS reported at -0.79, which could continue to affect investor sentiment.
TELO cerró en $0.73 el Friday, tras bajar -6.50%
Telomir Pharmaceuticals Inc (TELO) last closed at $0.7294, losing -6.50%. These facts feed the 1-day and 1-week TELO price prediction above.
Factores de la previsión
Los factores de la previsión de Telomir Pharmaceuticals Inc (TELO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de TELO, ordenadas por similitud.
Análisis de estacionalidad de TELO
Historically the probability of a positive November return for TELO is 0.00%. January offers the highest probability of a positive month at 70.00%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de TELO
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.88 | $2.30 | $2.68 | +215.43% |
| Dec 2026 | $1.78 | $2.03 | $2.35 | +178.98% |
En 2026, se proyecta que Telomir Pharmaceuticals Inc (TELO) oscile entre $1.78 y $2.68.
Previsión mensual de Telomir Pharmaceuticals Inc para 2026
En Nov de 2026, se proyecta que Telomir Pharmaceuticals Inc promedie $2.30, con un mínimo de $1.88 y un máximo de $2.68.
En Dec de 2026, se proyecta que Telomir Pharmaceuticals Inc promedie $2.03, con un mínimo de $1.78 y un máximo de $2.35.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.